Please login to the form below
EFPIA
This page shows the latest EFPIA news and features for those working in and with pharma, biotech and healthcare.
Who's calling the shots in European healthcare?
EFPIA: We’re looking forward to working with MEPs, the Commission and Council as they look to the next mandate. ... EFPIA recently set out its manifesto of nine concrete proposals:. Drive the evolution towards outcomes-focused healthcare systems.
Latest news
-
Von der Leyen elected new European Commission president
Europe’s pharma industry association EFPIA will be hoping for a strong Commission so that reforms – including pro-industry and pro-innovation policies – can be achieved over the next five years, ... EFPIA had fought against the changes, arguing
-
Ursula von der Leyen nominated for EU President role
Europe’s pharma association EFPIA has been careful not to comment on the formation of the new EU leadership, but is continuing to promote its agenda for the next five years. ... EFPIA yesterday called for a ‘refreshed approach’ to the plans,
-
European elections: Eurosceptics and Greens rise, but big parties hold on
Pharma’s perspective. While Europe’s pharma lobby group EFPIA has been as careful as ever to stay out of endorsing candidates, its leaders did urge Europeans to take part in ... EFPIA's Nathalie Moll. When the elections kicked off last week,
-
As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority
The programme is particularly vital in health research, and six European health industry associations, including the pharma sector’s EFPIA have thrown their weight behind the new framework, which creates ... Welcoming the agreement between EU’s
-
Pharma fears “lack of focus” on no-deal Brexit preparations
supply. That is the view of Merck KGaA chief executive and President of European pharma's EFPIA, Stefan Oschmann, who says that the pharma industry has “been concerned by a certain ... EFPIA president Stefan Oschmann . He suggests in a blog post on
More from news
Approximately 35 fully matching, plus 153 partially matching documents found.
Latest Intelligence
-
Leading AstraZeneca’s return to growth in Europe
Reic is in step with leaders at EFPIA in saying the EU needs to prioritise investment in science and R&D to maintain the region’s pre-eminence for life sciences.
-
How can we realise the benefits of patient engagement?
From EFPIA to the ABPI, guidance for working with patients and patient organisations is clear: pharma can and should engage with this important stakeholder.
-
A new EU in the making, what lies ahead for pharma?
EFPIA has set out its own manifesto, and it is obviously looking for some pro-business policies to help life sciences in Europe.
-
Brain power: fresh approaches to Alzheimer’s drug discovery
EPAD is co-funded by the Innovative Medicines Initiative (IMI) and Europe’s pharma industry organisation EFPIA, and 2019 will see the first patients being treated by this groundbreaking new alliance.
-
Uncertainty, austerity and Brexit
Life science companies, the ABPI and EFPIA have been clear that the UK and the EU need to provide businesses with ‘certainty’ so that they are able to create contingency plans
More from intelligence
Approximately 6 fully matching, plus 31 partially matching documents found.
Latest appointments
-
EFPIA appoints new director general
Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector. ... We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges
-
IFPMA appoints director general
Thomas Cueni brings expertise from Interpharma and EFPIA. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has selected Thomas Cueni as its new director general. ... Cueni also brings industry expertise from the
-
Bayer appoints president of Americas pharma business
He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.
-
Eric Cornut appointed EFPIA interim director general
Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee. ... work. “I am very pleased that Eric
-
EFPIA director general Richard Bergström resigns
Richard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post. ... Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe
More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
The changing face of medical communications over the past 15 years
Similarly, the launch of Disclosure UK’s searchable database, which went live in June 2016, is a helpful development for the UK (and Europe-wide through EFPIA), although details don’t
-
How Transparent Is Transparency?
So, what have we learnt? Is the EFPIA mission – to provide a greater understanding of the merits and ethics of the interactions between pharmaceutical companies and healthcare professionals (HCPs) – bearing any ... The EFPIA vision of enhanced
-
Brexit and Pharma: A match made in hell.
My husband and I woke up in the early hours of 24 June 2016 to the astonishing news that the UK had voted to leave the EU. It’s fair to say both of us shuddered and, while our perspectives were different, our concerns with regard to the complexity
-
Compliance Hub Ltd
Specialists in ABPI, ABHI and EFPIA codes of practice - provides training, audit and consultancy services.
-
Cameron Medical Communications Ltd
We specialise in: Marketing Codes of Practice, ABPI, EFPIA, IFPMA, Medical Information Systems and Services and Copyright.
More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.
Featured jobs
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive salary plus benefits
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
-
Senior Copywriter
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- UCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
- Merck seeks partner for disease-modifying osteoarthritis drug
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Allergan investors back AbbVie deal, but is a tax charge looming?
- What is changing in cardiovascular disease care?
- Tranexamic acid linked to lower death rate in some brain injury patients
- Horizon shares data on eye disease drug as FDA decision nears
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- 90TEN named Specialist Consultancy of the Year at 2019 PRWeek UK Awards
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- What is changing in cardiovascular disease care?
- Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
- PANDAS/PANS Awareness: A parent’s story
- To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
- Leading AstraZeneca’s return to growth in Europe
- PME talks to Iskra Reic, the company’s head of Europe and Canada...
Quick links
Infographics
